Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 3 art units • 5 examiners • 0 of 8 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Curium US LLC has 8 pending office actions in Biotechnology & Pharmaceuticals. The matters span 6 distinct examiners and 4 distinct art units, indicating both examiner dispersion and technical-unit grouping. Several matters therefore share art-unit coverage even though examiner assignments are distributed.
DONOHUE, SEAN R is the busiest examiner with 2 pending matters. That concentration identifies one examiner relationship requiring coordinated attention, while the remaining matters call for management across other examination channels. Counsel can combine portfolio-level technical review with examiner-specific preparation for the concentrated assignment.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (25%) |
| Double-patenting + other | 5 (62%) |
| Multi-statute (no §101) | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DONOHUE, SEAN R | 2 | 41.4% | +21.0% |
| LEWOCZKO, EVAN MICHAEL | 2 | — | — |
| WESTERBERG, NISSA M | 2 | 23.4% | +37.3% |
| CRAIG, KAILA ANGELIQUE | 1 | 33.8% | +25.2% |
| VU, JAKE MINH | 1 | 41.0% | +27.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18745888 | COPPER-64 COMPOSITIONS AND PURIFICATION PROCESSES FOR THE PREPARATION OF NOVEL COPPER-64 COMPOSITIONS | WESTERBERG, NISSA M | — |
| 18681264 | RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY | VU, JAKE MINH | — |
| 18354581 | RADIOPHARMACEUTICAL COMPOSITIONS OF COPPER FOR TARGETED MOLECULAR IMAGING | WESTERBERG, NISSA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19198982 | [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF | DONOHUE, SEAN R | — |
| 18798723 | METHOD OF DETECTING PROSTATE CANCER IN A HUMAN SUBJECT USING A Cu 64 PSMA I&T INJECTION | CRAIG, KAILA ANGELIQUE | — |
| 18756231 | RADIOLABELING AND FORMULATION FOR SCALE UP OF 64Cu-DOTATATE | DONOHUE, SEAN R | — |
| 18745888 | COPPER-64 COMPOSITIONS AND PURIFICATION PROCESSES FOR THE PREPARATION OF NOVEL COPPER-64 COMPOSITIONS | WESTERBERG, NISSA M | — |
| 18681264 | RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY | VU, JAKE MINH | — |
| 18354581 | RADIOPHARMACEUTICAL COMPOSITIONS OF COPPER FOR TARGETED MOLECULAR IMAGING | WESTERBERG, NISSA M | — |
| Art Unit | Apps |
|---|---|
| 1618 | 5 |
| 1612 | 2 |
| 4100 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19198982 | [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF | DONOHUE, SEAN R | 1618 | §103 | Final Rejection | — | Pending | May 05, 2025 |
| 19063049 | [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF | LEWOCZKO, EVAN MICHAEL | 1612 | §103DP | Final Rejection | — | Pending | Feb 25, 2025 |
| 18798723 | METHOD OF DETECTING PROSTATE CANCER IN A HUMAN SUBJECT USING A Cu 64 PSMA I&T INJECTION | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Final Rejection | — | Pending | Aug 08, 2024 |
| 18756231 | RADIOLABELING AND FORMULATION FOR SCALE UP OF 64Cu-DOTATATE | DONOHUE, SEAN R | 1618 | §102§103§112DP | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18745888 | COPPER-64 COMPOSITIONS AND PURIFICATION PROCESSES FOR THE PREPARATION OF NOVEL COPPER-64 COMPOSITIONS | WESTERBERG, NISSA M | 4100 | §103§112DP | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18681264 | RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY | VU, JAKE MINH | 1618 | §102§103§112Other | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18228510 | [177LU] LUTETIUM-PSMA I&T COMPOSITION, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF | LEWOCZKO, EVAN MICHAEL | 1612 | §103§112DP | Non-Final OA | — | Pending | Jul 31, 2023 |
| 18354581 | RADIOPHARMACEUTICAL COMPOSITIONS OF COPPER FOR TARGETED MOLECULAR IMAGING | WESTERBERG, NISSA M | 1618 | §103§112DP | Non-Final OA | — | Pending | Jul 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCurium US LLC has 8 pending office actions as of October 2026, spread across 3 art units and 5 examiners.
Sean R Donohue has the most, with 2 of Curium US LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
